avelumab
2017-05-046
Phase 2 small_molecule active
Quick answer
avelumab for Lymphoma, Extranodal NK-T-Cell is a Phase 2 program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Samsung Bioepis NL B.V.
- Indication
- Lymphoma, Extranodal NK-T-Cell
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active